Zhou J - Search Results

1

Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling.

Li S, Wang H, Hong L, Liu W, Huang F, Wang J, Wang P, Zhang X, Zhou J. Li S, et al. Among authors: zhou j. Cancer Biol Ther. 2015;16(1):176-84. doi: 10.4161/15384047.2014.962960. Cancer Biol Ther. 2015. PMID: 25482936 Free PMC article.

2

EphA3, induced by PC-1/PrLZ, contributes to the malignant progression of prostate cancer.

Wu R, Wang H, Wang J, Wang P, Huang F, Xie B, Zhao Y, Li S, Zhou J. Wu R, et al. Among authors: zhou j. Oncol Rep. 2014 Dec;32(6):2657-65. doi: 10.3892/or.2014.3482. Epub 2014 Sep 16. Oncol Rep. 2014. PMID: 25231727

3

The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.

Wang H, Huang F, Wang J, Wang P, Lv W, Hong L, Li S, Zhou J. Wang H, et al. Among authors: zhou j. Cell Cycle. 2015;14(2):232-42. doi: 10.4161/15384101.2014.977096. Cell Cycle. 2015. PMID: 25607647 Free PMC article.

4

PC-1 works in conjunction with E3 ligase CHIP to regulate androgen receptor stability and activity.

Wang J, Zhang H, Zhang X, Wang P, Wang H, Huang F, Zhou C, Zhou J, Li S. Wang J, et al. Among authors: zhou j, zhou c. Oncotarget. 2016 Dec 6;7(49):81377-81388. doi: 10.18632/oncotarget.13230. Oncotarget. 2016. PMID: 27835608 Free PMC article.

5

EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.

Lv XY, Wang J, Huang F, Wang P, Zhou JG, Wei B, Li SH. Lv XY, et al. Among authors: zhou jg. Oncol Rep. 2018 Oct;40(4):2408-2416. doi: 10.3892/or.2018.6586. Epub 2018 Jul 20. Oncol Rep. 2018. PMID: 30066881

6

SGEF is overexpressed in prostate cancer and contributes to prostate cancer progression.

Wang H, Wu R, Yu L, Wu F, Li S, Zhao Y, Li H, Luo G, Wang J, Zhou J. Wang H, et al. Among authors: zhou j. Oncol Rep. 2012 Oct;28(4):1468-74. doi: 10.3892/or.2012.1917. Epub 2012 Jul 19. Oncol Rep. 2012. PMID: 22824926

7

SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes.

Wang H, Li S, Li H, Li C, Guan K, Luo G, Yu L, Wu R, Zhang X, Wang J, Zhou J. Wang H, et al. Among authors: zhou j. Carcinogenesis. 2013 Sep;34(9):1976-83. doi: 10.1093/carcin/bgt157. Epub 2013 May 9. Carcinogenesis. 2013. PMID: 23661635

8

Grb2 interacts with SGEF and antagonizes the ability of SGEF to enhance EGF-induced ERK1/2 activation.

Wang H, Li S, Li H, Wang P, Huang F, Zhao Y, Yu L, Luo G, Zhang X, Wang J, Zhou J. Wang H, et al. Among authors: zhou j. Mol Cell Biochem. 2014 Apr;389(1-2):239-47. doi: 10.1007/s11010-013-1945-7. Epub 2014 Jan 8. Mol Cell Biochem. 2014. PMID: 24399467

9

Antitumor Effects of Oncolytic Adenovirus-Carrying siRNA Targeting Potential Oncogene EphA3.

Zhao Y, Li H, Wu R, Li S, Wang P, Wang H, Wang J, Zhou J. Zhao Y, et al. Among authors: zhou j. PLoS One. 2015 May 15;10(5):e0126726. doi: 10.1371/journal.pone.0126726. eCollection 2015. PLoS One. 2015. PMID: 25978371 Free PMC article.

10

PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability.

Yu L, Shang ZF, Wang J, Wang H, Huang F, Zhang Z, Wang Y, Zhou J, Li S. Yu L, et al. Among authors: zhou j. Oncotarget. 2015 Aug 21;6(24):20356-69. doi: 10.18632/oncotarget.3931. Oncotarget. 2015. PMID: 26011939 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,094 results

Search Page

Filters